Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancer.
Oermann EK, Suy S, Hanscom HN, Kim JS, Lei S, Yu X, Zhang G, Ennis B, Rohan JP, Piel N, Sherer BA, Borum D, Chen VJ, Batipps GP, Constantinople NL, Dejter SW, Bandi G, Pahira J, McGeagh KG, Adams-Campbell L, Jha R, Dawson NA, Collins BT, Dritschilo A, Lynch JH, Collins SP.
Oermann EK, et al. Among authors: collins bt, collins sp.
J Hematol Oncol. 2011 Mar 27;4:12. doi: 10.1186/1756-8722-4-12.
J Hematol Oncol. 2011.
PMID: 21439088
Free PMC article.